Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)

South Korea · Delayed Price · Currency is KRW

6,420.00

+100.00 (1.58%)

Nov 5, 2026, 3:30 PM KST

Market Cap	319.09B +42.5%
Revenue (ttm)	1.71T +5.5%
Net Income	21.82B -19.8%
EPS	478.71 -30.2%
Shares Out	49.70M
PE Ratio	13.41
Forward PE	n/a
Dividend	100.00 (1.56%)
Ex-Dividend Date	Mar 31, 2026

Volume	177,804
Open	6,310.00
Previous Close	6,320.00
Day's Range	6,310.00 - 6,550.00
52-Week Range	5,150.00 - 12,800.00
Beta	0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2026

About Kwang Dong Pharmaceutical

Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of ophthalmic, mineral preparations, nutritious tonics, antipyretic, analgesic, anti inflammatory agents, circulating system, and vitamins; and ETC drugs in the areas of anti-malignant-tumor agent, obesity drug, appetite suppressant, antipyretic, analgesic, anti-inflammatory agents, neuropsychiatric solvent, digestive organ agent, antibiotic, and vitamins. The company also offers supplements for low content vi... [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 1963

Employees 1,004

Stock Exchange Korea Stock Exchange

Ticker Symbol 009290

Full Company Profile

Financial Performance

In 2025, Kwang Dong Pharmaceutical's revenue was 1.66 trillion, an increase of 1.15% compared to the previous year's 1.64 trillion. Earnings were 20.97 billion, a decrease of -48.20%.

Financial Statements